In medulloblastomas, CD114+ cells exhibit all the characteristics expected in CSC: their presence in a small and undifferentiated number of cells; stronger resistance and higher percentage growth after chemotherapy treatment; and the potential for differentiation such as pluripotent embryogenic cells, in addition to the responsiveness of G-CSF granted by the receptor. This evidence concerns the gene CSF3 and medulloblastoma.